6Anzai Y,Heger-Mahn D,Schellschmidt I. Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women[J].Contraception,2011.28-34.
7O'Donnell RL,Warner P,Lee RJ. Physiological sex steroid replacement in premature ovarian failure:randomized crossover trial of effect on uterine volume,endometrial thickness and blood flow,compared with a standard regimen[J].Human Reproduction,2012.1130-1138.
8Lindh I,Ellstr(o)m AA,Milsom I. The effect of combined oral contraceptives and age on dysmenorrhoea:an epidemiological study[J].Human Reproduction,2012.676-682.
9Fruzzetti F. Beyaz:an oral contraceptive fortified with folate[J].Women's Health,2012.13-19.
10Kerscher M,Reuther T,Krueger N. Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception[J].Journal of the European Academy of Dermatology and Venereology,2012.1468-3083.
